- Home
- MRCC vs RGC Comparison
MRCC vs RGC Comparison
Compare MRCC & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRCC
- RGC
- Stock Information
- Founded
- MRCC 2011
- RGC 2014
- Country
- MRCC United States
- RGC Hong Kong
- Employees
- MRCC N/A
- RGC N/A
- Industry
- MRCC Investment Managers
- RGC Medicinal Chemicals and Botanical Products
- Sector
- MRCC Finance
- RGC Health Care
- Exchange
- MRCC Nasdaq
- RGC Nasdaq
- Market Cap
- MRCC 174.8M
- RGC 105.3M
- IPO Year
- MRCC 2012
- RGC 2021
- Fundamental
- Price
- MRCC $8.24
- RGC $4.86
- Analyst Decision
- MRCC Strong Buy
- RGC
- Analyst Count
- MRCC 1
- RGC 0
- Target Price
- MRCC $9.00
- RGC N/A
- AVG Volume (30 Days)
- MRCC 65.9K
- RGC 8.8K
- Earning Date
- MRCC 11-12-2024
- RGC 10-25-2024
- Dividend Yield
- MRCC 12.14%
- RGC N/A
- EPS Growth
- MRCC 298.01
- RGC N/A
- EPS
- MRCC 0.60
- RGC N/A
- Revenue
- MRCC $62,007,000.00
- RGC N/A
- Revenue This Year
- MRCC N/A
- RGC N/A
- Revenue Next Year
- MRCC N/A
- RGC N/A
- P/E Ratio
- MRCC $13.73
- RGC N/A
- Revenue Growth
- MRCC N/A
- RGC N/A
- 52 Week Low
- MRCC $6.97
- RGC $3.03
- 52 Week High
- MRCC $8.80
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- MRCC 46.26
- RGC 44.96
- Support Level
- MRCC $8.10
- RGC $4.75
- Resistance Level
- MRCC $8.80
- RGC $5.21
- Average True Range (ATR)
- MRCC 0.21
- RGC 0.30
- MACD
- MRCC -0.02
- RGC 0.04
- Stochastic Oscillator
- MRCC 23.29
- RGC 23.87
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.